Compare Neurocrine Biosciences Inc (NBIX) vs Public Storage (PSA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Public Storage — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Public Storage trades at $310.72 (market cap $55.40B). The key difference: Public Storage is far larger — about 3.2× Neurocrine Biosciences Inc's market cap, and Public Storage pays a 3.8% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | PSA | |
|---|---|---|
Market Cap | $17.40B | $55.40B |
Sector | Health | Real Estate |
52-Week High | $180.55 | $329.64 |
52-Week Low | $123.10 | $258.44 |
Enterprise Value | $16.49B | $69.65B |
Dividend Yield | — | 3.8% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Public Storage
Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →
